CliffBio
biologic

Mircera

methoxy polyethylene glycol-epoetin beta

Loss of exclusivityApril 2028projected — 12-year biologic exclusivity estimate
CompanyVifor (International) Inc.

Drug detail

Brand nameMircera
Active ingredientmethoxy polyethylene glycol-epoetin beta
Strength360MCG/0.6ML
Dosage formInjection
RouteIntravenous, Subcutaneous
ModalityBiologic
FDA approvalApril 2016
Marketing statusRx

More from Vifor (International) Inc.

Source: FDA Purple Book, layered on the CliffBio company graph. Cliff dates are the projected — 12-year biologic exclusivity estimate; estimates are projections, not legal advice.